| Geoffrey D Lifferth, MD | |
|
555 Hartsville Pike, Gallatin, TN 37066-2400 | |
| (615) 452-4210 | |
| Not Available |
| Full Name | Geoffrey D Lifferth |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine - Emergency Medical Services |
| Location | 555 Hartsville Pike, Gallatin, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922084102 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 36822 (Tennessee) | Primary |
| Entity Name | Emergency Physicians At Sumner Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538149521 PECOS PAC ID: 2062434160 Enrollment ID: O20060103000357 |
News Archive
Inter Press Service reports on a research study conducted in Argentina that "explored women's knowledge and beliefs about cervical cancer, in the provinces with the highest mortality from this highly preventable form of cancer, to design more effective policies."
A major California hospital chain, Sutter Health, agreed to pay $46 million and disclose more pricing information to consumers to resolve a whistle-blower complaint alleging false and misleading charges for anesthesia. Sutter Health, which runs 24 acute-care hospitals in Northern California, said it reached the settlement Monday just prior to a trial starting this month over the allegations that it added thousands of dollars for "Code 37x" anesthesia charges that were already covered by other billing for the hospital operating room (Terhune, 11/4).
Data presented today from an analysis of samples from the European Diabetes Prevention Study (EDIPS) showed that the PreDx Diabetes Risk Score (DRS) is lowered by lifestyle intervention, which correlates to a reduction in the risk that patients will develop diabetes over time.
Exelixis, Inc. today announced that it has regained full rights to develop and commercialize XL184. Exelixis and Bristol-Myers Squibb Company entered into a global development collaboration for XL184, the clinically most advanced MET inhibitor, in December 2008. Under the agreement, BMS and Exelixis had originally agreed to certain clinical development plans, and Exelixis maintained key rights regarding timing and funding of current and future clinical trials.
One in five patients is prescribed opioids after having a pacemaker or similar device implanted, according to a large US study conducted at Mayo Clinic published in HeartRhythm, the official journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society published by Elsevier.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Geoffrey D Lifferth, MD Po Box 8080, Gallatin, TN 37066-8080 Ph: (866) 321-8433 | Geoffrey D Lifferth, MD 555 Hartsville Pike, Gallatin, TN 37066-2400 Ph: (615) 452-4210 |
News Archive
Inter Press Service reports on a research study conducted in Argentina that "explored women's knowledge and beliefs about cervical cancer, in the provinces with the highest mortality from this highly preventable form of cancer, to design more effective policies."
A major California hospital chain, Sutter Health, agreed to pay $46 million and disclose more pricing information to consumers to resolve a whistle-blower complaint alleging false and misleading charges for anesthesia. Sutter Health, which runs 24 acute-care hospitals in Northern California, said it reached the settlement Monday just prior to a trial starting this month over the allegations that it added thousands of dollars for "Code 37x" anesthesia charges that were already covered by other billing for the hospital operating room (Terhune, 11/4).
Data presented today from an analysis of samples from the European Diabetes Prevention Study (EDIPS) showed that the PreDx Diabetes Risk Score (DRS) is lowered by lifestyle intervention, which correlates to a reduction in the risk that patients will develop diabetes over time.
Exelixis, Inc. today announced that it has regained full rights to develop and commercialize XL184. Exelixis and Bristol-Myers Squibb Company entered into a global development collaboration for XL184, the clinically most advanced MET inhibitor, in December 2008. Under the agreement, BMS and Exelixis had originally agreed to certain clinical development plans, and Exelixis maintained key rights regarding timing and funding of current and future clinical trials.
One in five patients is prescribed opioids after having a pacemaker or similar device implanted, according to a large US study conducted at Mayo Clinic published in HeartRhythm, the official journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society published by Elsevier.
› Verified 3 days ago
Dr. James Andrew Parnell, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 555 Hartsville Pike, Emergency Physicians At Sumner, Gallatin, TN 37066 Phone: 615-328-5981 | |
Charles S Ruark Jr., MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 555 Hartsville Pike, Gallatin, TN 37066 Phone: 615-452-4210 | |
Dr. Scott M Bradley, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 Hartsville Pike, Gallatin, TN 37066 Phone: 615-348-5833 Fax: 650-723-0121 | |
Dr. Steven T Riley, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 648 Hartsville Pike, Gallatin, TN 37066 Phone: 615-451-9246 Fax: 615-452-9410 | |
Aubrey Delk, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 555 Hartsville Pike, Emergency Department, Gallatin, TN 37066 Phone: 615-328-5203 | |
Kimberly Plourde, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 Hartsville Pike, Gallatin, TN 37066 Phone: 615-328-5750 | |
William R Little, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 555 Hartsville Pike, Gallatin, TN 37066 Phone: 615-452-4210 |